![Renejix CDMO Partner for Small Molecule Oral Dosage Forms](https://www.pharmacompass.com/image/flap/renejix-w35-desktop-header-01gif-33629.gif)
![Renejix CDMO Partner for Small Molecule Oral Dosage Forms](https://www.pharmacompass.com/image/flap/renejix-w35-mob-header-01gif-17728.gif)
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.prnewswire.com/news-releases/tavanta-therapeutics-to-showcase-specialty-pipeline-during-the-2023-american-society-of-clinical-oncology-asco-and-american-society-of-colon-and-rectal-surgeons-ascrs-annual-congresses-301838071.html
https://www.prnewswire.com/news-releases/tavanta-therapeutics-announces-new-preclinical-data-for-its-cystic-fibrosis-candidate-tavt-135-at-two-prominent-scientific-conferences-301832965.html
https://www.prnewswire.com/news-releases/tavanta-therapeutics-announces-positive-top-line-results-from-pivotal-phase-3-trial-of-tavt-45-for-the-treatment-of-metastatic-prostate-cancer-301714563.html
https://www.prnewswire.com/news-releases/tavanta-therapeutics-to-present-preclinical-data-for-tavt-135-at-the-north-american-cystic-fibrosis-conference-301662485.html